Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hyatt Hotels Corporation (H) vs Zoetis Inc (ZTS) Price & Performance

Hyatt Hotels CorporationTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Hyatt Hotels Corporation vs Zoetis Inc — how do they compare? Hyatt Hotels Corporation trades at $161.78 (market cap $15.02B), while Zoetis Inc trades at $74.76 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 2× Hyatt Hotels Corporation's market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold Hyatt Hotels Corporation for 148 Days and Zoetis Inc for 70 Days on average.

HZTS
Market Cap
$15.02B$30.20B
Volume
842,3406,175,327
Sector
Consumer CyclicalHealth
52-Week High
$202.09$147.53
52-Week Low
$135.42$69.09
Typical Hold Time
148 Days70 Days
Enterprise Value
$18.93B$37.76B
Dividend Yield
0.38%2.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hyatt Hotels Corporation

Hyatt Hotels (H) trades at $161.94, up 3.05% today, near its pivot point of $159 with resistance at $162. The stock shows mixed technical signals but has consistently beaten earnings estimates in recent quarters. Revenue grew to $7.10B in 2025, though net income was negative. Analyst consensus is a Moderate Buy with a $197.77 price target, supported by recent strategic collaborations like the Delta Air Lines loyalty partnership announced September 9, 2026.

The outlook is cautiously optimistic given strong fee growth and expansion plans, but high valuation (P/E 196.83) and debt levels pose risks. Earnings momentum from Q3 2026 results, due October 29, 2026, will be critical for sustaining upside. Investors face volatility from regional economic weakness and project delays, requiring patience despite long-term growth targets.

Zoetis Inc

Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.

Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.

Returns comparison

Trailing returns across standard periods

About Hyatt Hotels Corporation

Hyatt is an operator of 1,162 owned (5% of total rooms) and managed and franchise (95%) properties across roughly 20 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, and the wellness brand Miraval. Hyatt acquired Two Roads in November 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 66% Americas, 18% Asia-Pacific, and 16% rest of world.

Read more on H →

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS →